Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Harry L. Leider Stories

2011-03-17 12:15:00

BALTIMORE, March 17, 2011 /PRNewswire/ -- Patients undergoing opioid therapy for chronic pain who may not be following their prescription regimen have significantly higher overall healthcare costs, Ameritox Ltd. announced recently. The study was published in The American Journal of Managed Care. "Considering all of the discussion right now around healthcare reform and controlling healthcare spending, this study highlights an opportunity to better manage a costly and at-risk population of...

2008-09-10 12:00:09

Ameritox, the U.S. leader in pain prescription monitoring, is pleased to announce that Dr. Harry L. Leider, MD, MBA, FACPE, has joined the company as chief medical officer and senior vice president. Dr. Leider will lead a variety of progressive initiatives, ranging from clinical research, to physician education, as well as strategic programs related to product development and payor partnerships. For more than 20 years, Dr. Leider has been an effective and widely-respected force for...